Beam Therapeutics (BEAM) Asset Utilization Ratio (2020 - 2026)

Beam Therapeutics (BEAM) has 7 years of Asset Utilization Ratio data on file, last reported at 0.11 in Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.11, up 123.89% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.11 (up 123.89% YoY), and the FY2025 annual result was 0.11, up 118.18% from the prior year.
• Asset Utilization Ratio rose to 0.11 in Q1 2026 per BEAM's latest filing, from 0.1 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.29 in Q3 2024 and troughed at 0.04 in Q1 2022.
• A 5-year average of 0.11 and a median of 0.06 in 2023 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2022 and 2025: Asset Utilization Ratio jumped 176929.34% in 2022, then plunged 85.66% in 2025.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.05 in 2022, then soared by 506.87% to 0.27 in 2023, then sank by 79.67% to 0.06 in 2024, then soared by 79.27% to 0.1 in 2025, then grew by 10.64% to 0.11 in 2026.
• Business Quant data shows BEAM's Asset Utilization Ratio at 0.11 in Q1 2026, 0.1 in Q4 2025, and 0.04 in Q3 2025.